MedTrace Logo

Natural Supplements for Unipolar Depression

NCT00226356 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2017-04-18

No results posted yet for this study

Summary

This study is being conducted to determine the clinical response rate for the regimen of L-methionine, betaine and folate for unipolar depression.

Conditions

  • Unipolar Depression

Interventions

DRUG

Supplements of L-methionine, betaine and folate

Sponsors & Collaborators

  • National Alliance for Research on Schizophrenia and Depression

    collaborator OTHER

  • Cambridge Health Alliance

    lead OTHER

Principal Investigators

  • Robert T Dunn, MD, PhD · Cambridge Health Alliance

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-12-31
Primary Completion
2007-06-30
Completion
2008-09-17

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00226356 on ClinicalTrials.gov